Thirumaran Senguttuvan

Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial

Ruth Goodall, Sarah Meredith, Andrew Nunn et al. · The Lancet · 2022 · 145 citations · Full text

Public Health, Infectious Diseases, Pharmacotherapy +11

Predictors of mortality among hospitalized COVID-19 patients and risk score formulation for prioritizing tertiary care—An experience from South India

Gopalan Narendran, Sumathi Senthil, N Prabakar et al. · PLoS ONE · 2022 · 47 citations · Full text

Education, Biostatistics, Health Sciences +17

Factors associated with unexplained sudden deaths among adults aged 18-45 years in India – A multicentric matched case–control study

Manickam Ponnaiah, Tarun Bhatnagar, Rizwan Suliankachi Abdulkader et al. · International Journal of Microbiology Research · 2023 · 16 citations · Full text

Public Health, Infectious Diseases, Clinical Epidemiology +12

Predictors of unfavorable responses to therapy in rifampicin-sensitive pulmonary tuberculosis using an integrated approach of radiological presentation and sputum mycobacterial burden

Gopalan Narendran, Vignes Anand Srinivasalu, Ponnuraja Chinnayan et al. · PLoS ONE · 2021 · 14 citations · Full text

Medicine, Infectious Diseases, Radiology +17

Characteristics of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome and its influence on tuberculosis treatment outcomes in persons living with HIV

Gopalan Narendran, Keerthana Jyotheeswaran, Thirumaran Senguttuvan et al. · International Journal of Infectious Diseases · 2020 · 10 citations · Full text

Public Health, Immunology, Infectious Diseases +17